Get started
West Pharmaceutical Services Inc.WW

West Pharmaceutical Services Inc.

189.30EURD
−2.40−1.25%
At close at May 9, 19:33 GMT
EUR
No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

WPS chart


Full chart

WPS upcoming earnings


Next report date
≈
July 24
Report period
Q2 2025
EPS estimate
1.36 EUR
Revenue estimate
‪647.07 M‬ EUR

Key stats


Market capitalization
‪13.64 B‬ EUR
Dividend yield (indicated)
0.39%
Price to earnings Ratio (TTM)
33.80
Basic EPS (TTM)
5.94 EUR
Net income (FY)
‪475.94 M‬ EUR
Revenue (FY)
‪2.79 B‬ EUR
Shares float
‪71.41 M‬
Beta (1Y)
0.51

Employees


Employees (FY)
‪10.6 K‬
Change (1Y)
0
Revenue / Employee (1Y)
‪263.61 K‬ EUR
Net income / Employee (1Y)
‪44.90 K‬ EUR

About West Pharmaceutical Services, Inc.


Sector
Health Technology
Industry
Medical Specialties
CEO
Eric Mark Green
Website
westpharma.com
Headquarters
Exton
Founded
1923
FIGI
BBG000JL7576
West Pharmaceutical Services, Inc. engages in the manufacture and marketing of pharmaceuticals, biologics, vaccines, and consumer healthcare products. It operates through the Proprietary Products and Contract-Manufactured Products segments. The Proprietary Products segment offers proprietary packaging, containment solutions and drug delivery products, along with analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.

Financials


Performance
‪10.0%‬
‪12.1%‬
‪14.2%‬
‪16.3%‬
‪18.4%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪200.00 M‬‬
‪‪400.00 M‬‬
‪‪600.00 M‬‬
‪‪800.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪170.00 M‬‬
‪‪340.00 M‬‬
‪‪510.00 M‬‬
‪‪680.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪170.00 M‬‬
‪‪340.00 M‬‬
‪‪510.00 M‬‬
‪‪680.00 M‬‬
Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪‪150.00 M‬‬
‪‪300.00 M‬‬
‪‪450.00 M‬‬
‪‪600.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Earnings
Next:Jul 24, 2025
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪0.50‬
‪1.00‬
‪1.50‬
‪2.00‬
Actual
Estimate

WPS news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of WPS is 189.30 EUR — it has decreased by −1.25% in the past 24 hours. Watch West Pharmaceutical Services Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange West Pharmaceutical Services Inc. stocks are traded under the ticker WPS.
WPS stock has risen by 2.19% compared to the previous week, the month change is a 12.56% rise, over the last year West Pharmaceutical Services Inc. has showed a −43.93% decrease.
We've gathered analysts' opinions on West Pharmaceutical Services Inc. future price: according to them, WPS price has a max estimate of 285.45 EUR and a min estimate of 215.19 EUR. Watch WPS chart and read a more detailed West Pharmaceutical Services Inc. stock forecast: see what analysts think of West Pharmaceutical Services Inc. and suggest that you do with its stocks.
WPS reached its all-time high on Dec 29, 2021 with the price of 411.20 EUR, and its all-time low was 63.02 EUR and was reached on Sep 26, 2016. View more price dynamics on WPS chart.
See other stocks reaching their highest and lowest prices.
WPS stock is 1.40% volatile and has beta coefficient of 0.52. Track West Pharmaceutical Services Inc. stock price on the chart and check out the list of the most volatile stocks — is West Pharmaceutical Services Inc. there?
Today West Pharmaceutical Services Inc. has the market capitalization of ‪13.74 B‬, it has decreased by −2.71% over the last week.
Yes, you can track West Pharmaceutical Services Inc. financials in yearly and quarterly reports right on TradingView.
West Pharmaceutical Services Inc. is going to release the next earnings report on Jul 24, 2025. Keep track of upcoming events with our Earnings Calendar.
WPS earnings for the last quarter are 1.34 EUR per share, whereas the estimation was 1.13 EUR resulting in a 18.13% surprise. The estimated earnings for the next quarter are 1.36 EUR per share. See more details about West Pharmaceutical Services Inc. earnings.
West Pharmaceutical Services Inc. revenue for the last quarter amounts to ‪645.19 M‬ EUR, despite the estimated figure of ‪633.81 M‬ EUR. In the next quarter, revenue is expected to reach ‪647.07 M‬ EUR.
WPS net income for the last quarter is ‪83.01 M‬ EUR, while the quarter before that showed ‪125.67 M‬ EUR of net income which accounts for −33.95% change. Track more West Pharmaceutical Services Inc. financial stats to get the full picture.
Yes, WPS dividends are paid quarterly. The last dividend per share was 0.19 EUR. As of today, Dividend Yield (TTM)% is 0.39%. Tracking West Pharmaceutical Services Inc. dividends might help you take more informed decisions.
West Pharmaceutical Services Inc. dividend yield was 0.25% in 2024, and payout ratio reached 12.27%. The year before the numbers were 0.22% and 9.90% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of May 10, 2025, the company has ‪10.6 K‬ employees. See our rating of the largest employees — is West Pharmaceutical Services Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. West Pharmaceutical Services Inc. EBITDA is ‪700.10 M‬ EUR, and current EBITDA margin is 25.93%. See more stats in West Pharmaceutical Services Inc. financial statements.
Like other stocks, WPS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade West Pharmaceutical Services Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So West Pharmaceutical Services Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating West Pharmaceutical Services Inc. stock shows the sell signal. See more of West Pharmaceutical Services Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.